A detailed history of Kbc Group Nv transactions in Atri Cure, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 1,428 shares of ATRC stock, worth $51,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,428
Previous 1,428 -0.0%
Holding current value
$51,036
Previous $33,000 21.21%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$19.86 - $29.09 $5,362 - $7,854
270 Added 23.32%
1,428 $33,000
Q4 2023

Feb 13, 2024

BUY
$32.99 - $43.25 $38,202 - $50,083
1,158 New
1,158 $41,000

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.66B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.